Skip to main content
SpringerLink
Log in

Development of a Novel HPLC Method for the Analysis of Impurities in Meropenem and Identification of Unknown Impurities by 2D LC-IT-TOF MS

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A novel stability-indicating HPLC method for the quantitative determination of impurities in meropenem raw material was established and fully validated for the further improvement of the official monograph in Pharmacopeia. The method was carried out on a Shim-Pack CLC-ODS column with UV detection at 220 nm. The influences of different band columns, composition ratio of mobile phase, gradient elution procedure, and pH value of mobile phase on separation of impurities in meropenem were investigated. The parameters specificity, precision, linearity, range, accuracy, limit of detection, limit of quantitation, and robustness were studied according to the regulatory guidelines recommended by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The linear regression analysis results of EP impurity A and EP impurity B show that there is a good linear relationship between response and concentration, and the correlation coefficients are 0.9999 and 1.0000, respectively. The accuracy of EP impurity A and EP impurity B is between 90 and 104%. Through analysis, the LOD and LOQ values of EP impurities A and B were measured and found to be 0.22 and 0.74 µg mL-1, respectively. Moreover, three unknown degradation impurities in meropenem were identified by two-dimensional liquid chromatography tandem with high-resolution ion trap/time-of-flight mass spectrometry in electrospray ionization mode. Compared with the current method in Pharmacopeia, the developed method had greatly improved the separation and detection ability of impurities. The established method was highly specific, sensitive, and accurate for reliable routine quality control of meropenem raw material. The structures of unknown impurities were characterized based on the MS/MS data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Pfaller MA, Jones RN (1997) A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide. Diagn Microbiol Infect Dis. https://doi.org/10.1016/S0732-8893(97)00065-5

    Article  PubMed  Google Scholar 

  2. Blumer JL (1997) Meropenem: evaluation of a new generation carbapenem. Int J Antimicrob Agents. https://doi.org/10.1016/S0924-8579(96)00347-0

    Article  PubMed  Google Scholar 

  3. Wiseman LR, Wagstaff AJ, Brogden RN, Bryson HM (1995) Meropenem A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs. https://doi.org/10.2165/00003495-199550010-00007

    Article  PubMed  Google Scholar 

  4. Sun C, Wu J, Pan Y (2009) Characterization of novel hydrolysis products of carbapenems by electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. https://doi.org/10.1002/rcm.4240

    Article  PubMed  Google Scholar 

  5. Barnes J, Caldwell M, Curel P et al (1995) Meropenem: a new carbapenem with potential for treating bacterial meningitis. Drugs and Therapy Perspect. https://doi.org/10.2165/00042310-199506100-00001

    Article  Google Scholar 

  6. Bradley JS (1997) Meropenem: a new, extremely broad spectrum beta-lactam antibiotic for serious infections in pediatrics. Pediatr Infect Dis J. https://doi.org/10.1097/00006454-199703000-00002

    Article  PubMed  Google Scholar 

  7. Pharmacopoeia of the People’s Republic of China (2020) Edition 2020, Chemical Industry Press

  8. United States Pharmacopoeia (2019) 43th edn. United States Pharmacopeial Convention

  9. European Pharmacopoeia (2019) 10th edn. Council of Europe Strasbourg

  10. Japanese Pharmacopoeia (2016) 17th edn. Ministry of Health, Labour and Welfare

  11. ICH Harmonised Tripartite Guideline (2006) Impurities in new drug substances Q3A (R2). In: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use.

  12. Ren XJ, Zhou JJ, Hu FF, Wang J (2020) Study of the impurity profile and characteristic fragmentation of Δ3-isomers in cephapirin sodium using dual liquid chromatography coupled with ion trap/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. https://doi.org/10.1002/rcm.8948

    Article  PubMed  Google Scholar 

  13. Liu GJ, Zhu BQ, Ren XJ, Wang J (2020) Characterization of 28 unknown impurities in 16-membered macrolides by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry. J Pharm Biomed Anal. https://doi.org/10.1016/j.jpba.2020.113324

    Article  PubMed  PubMed Central  Google Scholar 

  14. Rao KT, Rao LV, Kandepi V (2020) A novel validated eco-friendly RP-UHPLC method for assay and related substances in meropenem. Indian J Chem 59:1148

    Google Scholar 

  15. Elragehy NA, Abdel-Moety EM, Hassan NY, Rezk MR (2008) Stability-indicating determination of meropenem in presence of its degradation products. Talanta. https://doi.org/10.1016/j.talanta.2008.06.045

    Article  PubMed  Google Scholar 

  16. Barbosa FS, Pezzi LC, Tsao M, Mendez A et al (2020) Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: quantitative method and identification of degradation products. J Pharm Biomed Anal. https://doi.org/10.1016/j.jpba.2019.112973

    Article  Google Scholar 

  17. Mendez A, Chagastelles P, Palma E, Nardi N, Schapoval E (2008) Thermal and alkaline stability of meropenem: degradation products and cytotoxicity. Int J Pharm. https://doi.org/10.1016/j.ijpharm.2007.08.023

    Article  PubMed  Google Scholar 

  18. Takeuchi Y, Sunagawa M, Isobe Y, Hamazume Y, Noguchi T (1995) Stability of a 1β-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution. Chem Pharm Bull. https://doi.org/10.1248/cpb.43.689

    Article  Google Scholar 

  19. Cai SY, Hu CQ (2005) Chromatographic determination of polymerized impurities in meropenem. J Pharm Biomed Anal. https://doi.org/10.1016/j.jpba.2004.11.023

    Article  PubMed  Google Scholar 

  20. ICH Harmonized Tripartite Guideline (1994) Validation of Analytical Procedures: Text and Methodology Q2 (R1). In: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use.

  21. ICH Harmonized Tripartite Guideline (2003) Stability Testing of New Drug Substances and Products Q1A (R2). In: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use.

Download references

Acknowledgements

This study was supported by the Science and Technology project of Zhejiang Food and Drug Administration in 2020 (No. 202001), and National Science and Technology Major Projects for “Major New Drugs Innovation and Development” (No. 2017ZX09101001, Beijing, China).

Author information

Authors and Affiliations

  1. Zhejiang University of Technology, Hangzhou, 310014, China

    Xiaojuan Ren, Guijun Liu & Jian Wang

  2. Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd, Taizhou, 317016, China

    Jingjing Ye & Xianming Chen

  3. School of Medicine, Zhejiang University, Hangzhou, 310058, China

    Fan Wang

  4. Key Laboratory for Core Technology of Generic Drug Evaluation National Medical Product Administration, Zhejiang Institute for Food and Drug Control, Hangzhou, 310052, China

    Jian Wang

Authors
  1. Xiaojuan Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingjing Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xianming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guijun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 733 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, X., Ye, J., Chen, X. et al. Development of a Novel HPLC Method for the Analysis of Impurities in Meropenem and Identification of Unknown Impurities by 2D LC-IT-TOF MS. Chromatographia 84, 937–947 (2021). https://doi.org/10.1007/s10337-021-04081-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-021-04081-4

Keywords

Search

Navigation